Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Side effect management and procedural best practices with indwelling intravesical drug-releasing systems in the treatment of bladder cancer: recommendations from expert panels.
Journal: Current opinion in urology
Published: October 09, 2025
Erratum: TAR-200 for Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 09, 2025
TAR-200 for Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 30, 2025
Using patient-reported outcomes from the PROCLAIM trial to assess the impact of universal germline genetic testing for prostate cancer patients.
Journal: Prostate cancer and prostatic diseases
Published: February 19, 2025
A shared-care approach to the management of patients with mHSPC: the urology perspective.
Journal: Clinical advances in hematology & oncology : H&O
Published: November 07, 2024
Managing patients with metastatic hormone-sensitive prostate cancer: a shared-care approach to combination therapy.
Journal: Clinical advances in hematology & oncology : H&O
Published: November 07, 2024
The importance of the shared-care approach when triplet therapy is selected in mHSPC: Q&A.
Journal: Clinical advances in hematology & oncology : H&O
Published: November 07, 2024
Clinician-Reported Management Recommendations in Response to Universal Germline Genetic Testing in Patients With Prostate Cancer.
Journal: The Journal of urology
Published: August 09, 2024
The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
Journal: The Journal of urology
Published: August 09, 2023
Efficacy of National Comprehensive Cancer Network Guidelines in Identifying Pathogenic Germline Variants Among Unselected Patients with Prostate Cancer: The PROCLAIM Trial.
Journal: European urology oncology
Published: March 16, 2023
Showing 1-12 of 12
Last Updated: 09/26/2026